BioLife Solutions, Inc. (BLFS)
Oct 6, 2026 - BLFS was delisted (reason: acquired by RGEN)
38.61
+1.31 (3.51%)
Inactive · Last trade price on Oct 5, 2026

BioLife Solutions Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
106.6996.2174.6568.0276.24119.16
Revenue Growth
30.12%28.89%9.75%-10.79%-36.02%147.79%
Gross Profit
67.8762.1250.141.3246.9138.18
Operating Income
1.75-1.08-4.48-19.4-10.68-29.52
Net Income
57.98-4.6-20.18-68-139.81-8.91
Earnings Per Share
1.16-0.10-0.44-1.56-3.29-0.23
EPS Growth
------

Revenue by Geography

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
United States
83.5376.9755.9955.0962.52101.28
Europe, Middle East, Africa (EMEA)
16.313.4714.188.169.1513.11
Other
6.865.774.484.764.574.77
Total
106.6996.2174.6568.0276.24119.16

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
113.07120.18105.3644.7362.769.86
Total Debt
15.7417.930.0433.8343.7126.88
Net Cash (Debt)
97.33102.2875.3210.9118.9942.98
Net Cash Growth
27.36%35.79%590.69%-42.57%-55.82%-45.77%
Net Cash Per Share
1.962.101.640.250.441.12

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
16.8820.128.43-12.5-8.49-4.59
Capital Expenditures
-9.24-10.36-5.3-11.24-13.92-14.76
Free Cash Flow
7.639.753.14-23.74-22.41-19.35
Free Cash Flow Growth
-29.73%210.94%----

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
63.61%64.56%67.11%60.75%61.53%32.04%
Operating Margin
1.64%-1.12%-6.00%-28.52%-14.01%-24.77%
Pretax Margin
6.40%-12.56%-11.82%-17.97%-6.36%-24.36%
Profit Margin
54.35%-4.78%-27.04%-99.98%-183.38%-7.48%
FCF Margin
7.16%10.13%4.20%-34.90%-29.39%-16.24%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
134.67299.08223.59223.59223.59223.59
P/FCF Ratio
247.38119.40384.00---
PS Ratio
17.7012.1016.1310.7610.2113.03